7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

NovaBay Pharmaceuticals, Inc
(NYSE MKT:NBY) 

NBY stock logo

NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including t...

Founded: 2000
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
NovaBay Pharmaceuticals Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 011.322.6133.9145.2256.5267.8379.13
NovaBay Pharmaceuticals Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 09.1618.3227.4836.6445.854.9664.13
NovaBay Pharmaceuticals Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 045.9391.86137.79183.73229.66275.59321.52
NovaBay Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.76-9.22-7.69-6.15-4.61-3.07-1.540
NovaBay Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.99-9.42-7.85-6.28-4.71-3.14-1.570
NovaBay Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.242.483.724.966.197.438.67
NovaBay Pharmaceuticals P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.170.340.520.690.861.031.2
NovaBay Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.59-2.22-1.85-1.48-1.11-0.74-0.370
NovaBay Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.110.220.330.440.550.660.78
No extra charts and metrics for this ticker.